Minerva Neurosciences | NERV - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Minerva Neurosciences

Minerva Neurosciences reported $-6970000 in Pre-Tax Profit for its fiscal quarter ending in March of 2023.


Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -44939000 4.05M
AstraZeneca AZN:LN USD 3.71B 1.41B
Esperion Therapeutics ESPR:US USD -61719000 6.23M
Halozyme Therapeutics HALO:US USD 52.24M 18.55M
Ionis Pharmaceuticals IONS:US USD -113000000 81M
J&J JNJ:US USD 8.47B 1.05B
Marinus Pharmaceuticals MRNS:US USD -34730000 2.05M
Merck & Co MRK:US USD 4.48B 411M
Minerva Neurosciences NERV:US USD -6970000 244K
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
Novavax NVAX:US USD -292722000 108.21M
Roche Holding ROG:VX CHF 8.85B 3.26B
Takeda 4502:JP JPY 47.92B 59.24B